Gemzar 1 gm/vial (IV Infusion)
1 gm vial: ৳ 10,916.00
Medicine Details
Category | Details |
---|---|
Generic | Gemcitabine |
Company | Eli lilly and company |
Also available as |
Indications
- Non-Small Cell Lung Cancer treatment
- First-line treatment of locally advanced or metastatic non-small cell lung cancer
- Palliative treatment of adult patients with non-small cell lung cancer
- Treatment of locally advanced or metastatic adenocarcinoma of the pancreas
- Treatment of 5-FU refractory pancreatic cancer
- Treatment of advanced bladder cancer in combination with Cisplatin therapy
- Treatment of metastatic breast cancer in patients who have relapsed following adjuvant/neoadjuvant chemotherapy
- Treatment of recurrent epithelial ovarian carcinoma in patients who have relapsed following platinum-based therapy
Pharmacology
- Metabolism by nucleoside kinases
- Cytotoxic action: inhibition of DNA synthesis
- Inhibition of ribonucleotide reductase
- Competition with dCTP for incorporation into DNA
- Induction of the programmed cellular death process known as apoptosis
Dosage & Administration
- Recommended dosage for Non-Small Cell Lung Cancer
- Recommended dosage for Pancreatic Cancer
- Recommended dosage for Bladder Cancer
- Recommended dosage for Breast Cancer
- Recommended dosage for Ovarian Cancer
- Dosing regimens for combination use
- Dose reduction based on toxicity experienced by the patient
Interaction
- No confirmed interactions reported
- No specific drug interaction studies conducted
Contraindications
- Contraindicated in patients with known hypersensitivity to Gemcitabine
Side Effects
- Haematological Toxicity
- Hepatic Toxicity
- Gastrointestinal toxicity
- Genito-Urinary Toxicity
- Pulmonary Toxicity
- Allergic Toxicity
- Neurotoxicity
- Alopecia
Pregnancy & Lactation
- Pregnancy Category D
- Use during pregnancy
- Unknown excretion in human breast milk
Precautions & Warnings
- Risk of Schedule-dependent Toxicity
- Myelosuppression
- Pulmonary Toxicity and Respiratory Failure
- Hemolytic Uremic Syndrome
- Hepatic Toxicity
- Embryofetal Toxicity
- Radiation Therapy Toxicity
- Impairment of Fertility
Use in Special Populations
- Elderly Patients
- Renal and Hepatic Impairment
- Use in Children
Overdose Effects
- No known antidote for overdoses
- Myelosuppression
- Paresthesias
- Severe rash
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Store at 20-25°C away from light
- Do not refrigerate as crystallisation may occur
- Keep out of the reach of children
Related Brands
- Gemzen 200 mg/vial (IV Infusion) - beximco-pharmaceuticals-ltd
- Gemzen 1 gm/vial (IV Infusion) - beximco-pharmaceuticals-ltd
- Gemtor 1 gm/vial (IV Infusion) - eskayef-pharmaceuticals-ltd
- Gemtor 200 mg/vial (IV Infusion) - eskayef-pharmaceuticals-ltd
- Gembine 1 gm/vial (IV Infusion) - healthcare-pharmaceuticals-ltd